These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 13741918)
21. [Clinical experience with the preparation, Faseina (combination of reserpine and orphenadrine)]. MASCELLANI A Arcisp S Anna Ferrara; 1960; 13():1023-31. PubMed ID: 13767717 [No Abstract] [Full Text] [Related]
22. Occupational therapy for men. BARRETT JE Va Med Mon (1918); 1956 Jan; 83(1):29-30. PubMed ID: 13282229 [No Abstract] [Full Text] [Related]
23. Physiological factors underlying therapeutic success in mental disorders. DOUST JW Can Med Assoc J; 1953 Aug; 69(2):108-14. PubMed ID: 13067045 [No Abstract] [Full Text] [Related]
24. Management of psychological issues in conjunction with physical treatment. ALEXANDER L; ROSEN IM Dis Nerv Syst; 1955 Aug; 16(8):232-6. PubMed ID: 13241323 [No Abstract] [Full Text] [Related]
26. [Levomepromazin (nozinan, 7044 R. P.) in the treatment of mental disorders]. RIDANOVIC S Neuropsihijatrija; 1961; 9():63-76. PubMed ID: 13741463 [No Abstract] [Full Text] [Related]
27. [The value of occupational therapy in a psychiatric institution]. DU BOEUFF CW Folia Psychiatr Neurol Neurochir Neerl; 1956 Apr; 59(2):184-94. PubMed ID: 13344664 [No Abstract] [Full Text] [Related]
28. [Some remarks on pharmacology and psychiatry]. Rumke HC Encephale; 1956; 45(4):339-43. PubMed ID: 13384227 [No Abstract] [Full Text] [Related]
30. [Clinical experience with a new product, Insidon, indicated for psycho-vegetative symptoms in medical practice]. DONZALLAZ EJ Praxis; 1961 Oct; 50():1094-6. PubMed ID: 13887290 [No Abstract] [Full Text] [Related]
31. [Tissue therapy in neuropsychiatry]. SABATINI R Riv Patol Nerv Ment; 1953; 74(1):250-2. PubMed ID: 13101571 [No Abstract] [Full Text] [Related]
32. [Psycho-pharmacology and psychiatric medications]. Delay J; Deniker P Acquis Med Recent; 1957; 1957():195-207. PubMed ID: 13532178 [No Abstract] [Full Text] [Related]
33. [Experience in the neuropsychiatric field with a new psychoanaleptic agent (ANP 235)]. DE GREGORIO G; FRASCELLA G Rass Studi Psichiatr; 1961; 50():809-17. PubMed ID: 13884210 [No Abstract] [Full Text] [Related]
34. [Results of clinical studies on Meprotan]. KORKINA MV; NARODITSKAIA VF; STREL'TSOVA ZG Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():886-9. PubMed ID: 13753172 [No Abstract] [Full Text] [Related]
35. [A year's experience with LSD treatment]. ANDERSEN H Nord Psykiatr Tidsskr; 1962; 16():99-102. PubMed ID: 13861167 [No Abstract] [Full Text] [Related]
36. Psychiatric rehabilitation in the community. WILLIAMS RH Public Health Rep (1896); 1953 Dec; 68(12):1231-6. PubMed ID: 13121187 [No Abstract] [Full Text] [Related]
37. Care of mental patients. FLEMMING AS Public Health Rep (1896); 1959 Jul; 74(7):656-8. PubMed ID: 13668015 [No Abstract] [Full Text] [Related]
38. Response to wonder drugs. ALLEN A; MACKINNON HL Dis Nerv Syst; 1956 Aug; 17(8):262-3. PubMed ID: 13344337 [No Abstract] [Full Text] [Related]
39. [The main instruments of psychiatric after-care]. AMIEL R; BAUME S Tech Hosp Med Soc Sanit; 1957 Nov; 13(146):31-6 concl. PubMed ID: 13519408 [No Abstract] [Full Text] [Related]
40. [The main instruments of psychiatric after-care]. AMIEL R; BAUME S Tech Hosp Med Soc Sanit; 1957 Oct; 12(145):50-5 contd. PubMed ID: 13486518 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]